The value of the electrocardiogram in the recognition of cardiac amyloidosis: a systematic meta-analysis
Authors:
Open Access
- 13 September 2024
- journal article
- review article
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 24 (1) , 1-11
Abstract
We conducted a systematic review and meta-analysis to assess the diagnostic value of the electrocardiogram (ECG) method in detecting cardiac amyloidosis (CA) to indicate its clinical application. We searched PubMed, Web of Science, OVID Medline, and Cochrane Library databases for clinical trials assessing the diagnostic performance of ECG in detecting CA. We employed the risk ratio and 95% confidence interval (CI) to explicit estimates. QUADAS-2 was applied to evaluate the bias risk and the clinical applicability of the included studies. Reviewer Manager (RevMan) 5.3 and Stata 16.0 were employed to complete all statistical analyses. This meta-analysis included ten studies (N = 6353 patients). Overall, the findings of the study exposed that, for CA patients in whom the ECG method was used, the sensitivity and specificity were 0.49 and 0.91, respectively. The positive likelihood ratio (LR) and negative LR were 5.17 and 0.57, respectively. The diagnostic odds ratio (DOR) and diagnostic score of the ECG in detecting CA were 9.11 and 2.21. The area under the curve (AUC) was 0.83(95% CI = 0.79–0.86). The hierarchical summary receiver operating characteristic (HSROC) curve further confirmed the diagnostic accuracy of the ECG, demonstrating a high prediction and confidence interval for the pooled estimate. No significant publication bias was detected, as confirmed by funnel plot analysis. Sensitivity analysis confirmed that the pooled estimates for ECG remained stable after the exclusion of individual studies, underscoring the robustness of the findings. The combined DOR and diagnostic score were 9.11 and 2.21, respectively. ECM has low sensitivity and high specificity in the diagnosis of CA. AUC > 0.5, indicating that ECM has accuracy and diagnostic value in the diagnosis of CA to some extent.Keywords
This publication has 28 references indexed in Scilit:
- Predicting pacemaker implantation in cardiac amyloidosis: let's start with an ECGEuropean Journal of Heart Failure, 2022
- Multimodality imaging approach to cardiac amyloidosis: part 2Heart Failure Reviews, 2021
- Kardiale Amyloidose und AortenklappenstenoseHerz, 2021
- Electrocardiogram Criteria to Diagnose Cardiac Amyloidosis in Men With a Bundle Branch BlockThe American Journal of Cardiology, 2021
- Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology W orking G roup on M yocardial and P ericardial D iseasesEuropean Journal of Heart Failure, 2021
- A multi-modal diagnostic model improves detection of cardiac amyloidosis among patients with diagnostic confirmation by cardiac biopsyAmerican Heart Journal, 2021
- Cardiac amyloidosis: in search of the ideal diagnostic toolHerz, 2019
- A novel ECG parameter for diagnosis of acute pulmonary embolism: RS timeThe American Journal of Emergency Medicine, 2019
- Advances in the diagnosis and treatment of transthyretin amyloidosis with cardiac involvementHeart Failure Reviews, 2019
- Usefulness of Combining Electrocardiographic and Echocardiographic Findings and Brain Natriuretic Peptide in Early Detection of Cardiac Amyloidosis in Subjects With Transthyretin Gene MutationThe American Journal of Cardiology, 2015